Home
Find a Pharmacy
Health News
Medications
Conditions
RxCoupons
Pharmacy Solutions
Find a Pharmacy
Health News
Medications
Conditions
RxCoupons
Pharmacy Solutions
Health News
FDA approves Firazyr
The U.S. Food and Drug Administration today approved Firazyr ( icatibant ) Injection for the treatment of acute attacks of a rare condition called hereditary angioedema ( HAE ) in people ages 18 years and older.
REFINE
medications
Remove Firazyr filter
(-)
Remove Firazyr filter
Firazyr
conditions
Apply Cardiovascular filter
Cardiovascular (1)
Apply Cardiovascular filter